Puma Biotechnology | PBYI - صافي الدخل





صافي الدخل تغيير تاريخ
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 244.53M 50.95M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Incyte USD 303.33M 4.05M 2026-03
MacroGenics USD -14.16M 30.98M 2025-12
Moderna USD -1.34B 517M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Takeda JPY 103.64B 115.44B 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03